25 XP   0   0   10

Pangaea Oncology S.A.
Buy, Hold or Sell?

Let's analyse Pangaea Oncology S.A. together

PenkeI guess you are interested in Pangaea Oncology S.A.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Pangaea Oncology S.A.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Pangaea Oncology S.A.

I send you an email if I find something interesting about Pangaea Oncology S.A..

Quick analysis of Pangaea Oncology S.A. (30 sec.)










What can you expect buying and holding a share of Pangaea Oncology S.A.? (30 sec.)

How much money do you get?

How much money do you get?
‚ā¨0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
‚ā¨0.76
Expected worth in 1 year
‚ā¨1.32
How sure are you?
66.7%

+ What do you gain per year?

Total Gains per Share
‚ā¨0.56
Return On Investment
31.6%

For what price can you sell your share?

Current Price per Share
‚ā¨1.77
Expected price per share
‚ā¨1.69 - ‚ā¨1.8
How sure are you?
50%

1. Valuation of Pangaea Oncology S.A. (5 min.)




Live pricePrice per Share (EOD)

‚ā¨1.77

2. Growth of Pangaea Oncology S.A. (5 min.)




Is Pangaea Oncology S.A. growing?

Current yearPrevious yearGrowGrow %
How rich?$24.8m$15.1m$11m42.1%

How much money is Pangaea Oncology S.A. making?

Current yearPrevious yearGrowGrow %
Making money-$1.4m-$793k-$666.9k-45.7%
Net Profit Margin-63.0%-34.5%--

How much money comes from the company's main activities?

3. Financial Health of Pangaea Oncology S.A. (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  

What can you expect buying and holding a share of Pangaea Oncology S.A.? (5 min.)

Welcome investor! Pangaea Oncology S.A.'s management wants to use your money to grow the business. In return you get a share of Pangaea Oncology S.A..

What can you expect buying and holding a share of Pangaea Oncology S.A.?

First you should know what it really means to hold a share of Pangaea Oncology S.A.. And how you can make/lose money.

Speculation

The Price per Share of Pangaea Oncology S.A. is ‚ā¨1.77. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pangaea Oncology S.A..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pangaea Oncology S.A., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ‚ā¨0.76. Based on the TTM, the Book Value Change Per Share is ‚ā¨0.14 per quarter. Based on the YOY, the Book Value Change Per Share is ‚ā¨0.48 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ‚ā¨0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pangaea Oncology S.A..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ‚ā¨% of Price per Share‚ā¨% of Price per Share‚ā¨% of Price per Share‚ā¨% of Price per Share‚ā¨% of Price per Share
Usd Eps-0.06-3.6%-0.05-2.7%-0.03-1.5%-0.04-2.3%-0.04-2.3%
Usd Book Value Change Per Share-0.09-4.9%0.158.5%0.5229.1%0.2715.4%0.2715.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.09-4.9%0.158.5%0.5229.1%0.2715.4%0.2715.4%
Usd Price Per Share1.77-1.74-1.67-1.72-1.72-
Price to Earnings Ratio-6.99--10.06--15.46--11.86--11.86-
Price-to-Total Gains Ratio-20.17--7.87-3.23--4.17--4.17-
Price to Book Ratio2.16-2.03-3.23-2.43-2.43-
Price-to-Total Gains Ratio-20.17--7.87-3.23--4.17--4.17-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.905759
Number of shares524
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.150.27
Usd Total Gains Per Share0.150.27
Gains per Quarter (524 shares)78.89142.55
Gains per Year (524 shares)315.55570.20
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
103163060570560
20631622011401130
30947938017111700
4012621254022812270
5015781570028512840
6018931886034213410
7022092202039913980
8025242518045624550
9028402834051325120
10031553150057025690

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.02.00.00.0%0.03.00.00.0%0.03.00.00.0%0.03.00.00.0%0.03.00.00.0%
Book Value Change Per Share1.01.00.050.0%2.01.00.066.7%2.01.00.066.7%2.01.00.066.7%2.01.00.066.7%
Dividend per Share0.00.02.00.0%0.00.03.00.0%0.00.03.00.0%0.00.03.00.0%0.00.03.00.0%
Total Gains per Share1.01.00.050.0%2.01.00.066.7%2.01.00.066.7%2.01.00.066.7%2.01.00.066.7%

Fundamentals of Pangaea Oncology S.A.

About Pangaea Oncology S.A.

Pangaea Oncology, S.A., a medical services company, provides a range of services to cancer patients in Spain and the rest of European Union countries. The company offers molecular diagnostics, such as mutation analysis in tumor tissue and blood, gene amplification and translocation testing, immunohistochemistry, and gene expression; clinical trials; in vitro drug profiling, including MTT proliferation assays, western blotting, colony formation, migration and invasion assays, and gene silencing; and Dx platform, which performs companion diagnostic platform validation, validation against commercially available platforms, and Ad-hoc R+D for diagnostics companies. It also provides biomarker discovery to identify novel targets for targeted therapies in pre-clinical development. Pangaea Oncology, S.A. was founded in 2006 and is based in Barcelona, Spain.

Fundamental data was last updated by Penke on 2024-05-31 11:03:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Pangaea Oncology S.A..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit¬†Pangaea Oncology S.A. earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare¬†Pangaea Oncology S.A. to the¬†Diagnostics & Research industry mean.
  • A Net Profit Margin of -85.0%¬†means that¬†€-0.85 for each €1¬†in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Pangaea Oncology S.A.:

  • The MRQ is -85.0%. The company is making a huge loss. -2
  • The TTM is -63.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-85.0%TTM-63.0%-22.1%
TTM-63.0%YOY-34.5%-28.5%
TTM-63.0%5Y-53.5%-9.5%
5Y-53.5%10Y-53.5%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-85.0%-11.3%-73.7%
TTM-63.0%-11.3%-51.7%
YOY-34.5%-4.4%-30.1%
5Y-53.5%-3.3%-50.2%
10Y-53.5%-2.1%-51.4%
1.1.2. Return on Assets

Shows how efficient Pangaea Oncology S.A. is using its assets to generate profit.

  • Above 5% is considered healthy¬†but always compare¬†Pangaea Oncology S.A. to the¬†Diagnostics & Research industry mean.
  • -6.3% Return on Assets means that¬†Pangaea Oncology S.A. generated¬†€-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Pangaea Oncology S.A.:

  • The MRQ is -6.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -4.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.3%TTM-4.6%-1.7%
TTM-4.6%YOY-3.5%-1.0%
TTM-4.6%5Y-4.2%-0.3%
5Y-4.2%10Y-4.2%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.3%-2.6%-3.7%
TTM-4.6%-2.3%-2.3%
YOY-3.5%-0.7%-2.8%
5Y-4.2%-0.4%-3.8%
10Y-4.2%-0.4%-3.8%
1.1.3. Return on Equity

Shows how efficient Pangaea Oncology S.A. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare¬†Pangaea Oncology S.A. to the¬†Diagnostics & Research industry mean.
  • -7.7% Return on Equity means Pangaea Oncology S.A. generated €-0.08¬†for each¬†€1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Pangaea Oncology S.A.:

  • The MRQ is -7.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -5.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.7%TTM-5.7%-2.1%
TTM-5.7%YOY-5.2%-0.5%
TTM-5.7%5Y-5.5%-0.2%
5Y-5.5%10Y-5.5%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.7%-1.5%-6.2%
TTM-5.7%-1.9%-3.8%
YOY-5.2%-0.3%-4.9%
5Y-5.5%-1.3%-4.2%
10Y-5.5%-1.3%-4.2%

1.2. Operating Efficiency of Pangaea Oncology S.A..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Pangaea Oncology S.A. is operating .

  • Measures how much profit Pangaea Oncology S.A. makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare¬†Pangaea Oncology S.A. to the¬†Diagnostics & Research industry mean.
  • An Operating Margin of 0.0%¬†means the company generated €0.00 ¬†for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Pangaea Oncology S.A.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--17.3%+17.3%
TTM--10.8%+10.8%
YOY-1.6%-1.6%
5Y--1.4%+1.4%
10Y-1.8%-1.8%
1.2.2. Operating Ratio

Measures how efficient Pangaea Oncology S.A. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to¬†Diagnostics & Research industry mean).
  • An Operation Ratio of 0.71 means that the operating costs are €0.71 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Pangaea Oncology S.A.:

  • The MRQ is 0.705. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.510. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.705TTM0.510+0.196
TTM0.510YOY0.266+0.243
TTM0.5105Y0.429+0.081
5Y0.42910Y0.4290.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7051.369-0.664
TTM0.5101.329-0.819
YOY0.2661.301-1.035
5Y0.4291.257-0.828
10Y0.4291.194-0.765

1.3. Liquidity of Pangaea Oncology S.A..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Pangaea Oncology S.A. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to¬†Diagnostics & Research industry mean).
  • A Current Ratio of 4.89¬†means the company has €4.89 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Pangaea Oncology S.A.:

  • The MRQ is 4.886. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.944. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.886TTM4.944-0.058
TTM4.944YOY2.362+2.583
TTM4.9445Y4.083+0.861
5Y4.08310Y4.0830.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ4.8862.028+2.858
TTM4.9442.238+2.706
YOY2.3622.753-0.391
5Y4.0832.906+1.177
10Y4.0833.056+1.027
1.3.2. Quick Ratio

Measures if Pangaea Oncology S.A. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but¬†always compare¬†Pangaea Oncology S.A. to the¬†Diagnostics & Research industry mean.
  • A Quick Ratio of 5.01¬†means the company can pay off €5.01 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Pangaea Oncology S.A.:

  • The MRQ is 5.008. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.948. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.008TTM4.948+0.060
TTM4.948YOY2.336+2.612
TTM4.9485Y4.078+0.871
5Y4.07810Y4.0780.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ5.0081.235+3.773
TTM4.9481.247+3.701
YOY2.3361.774+0.562
5Y4.0781.957+2.121
10Y4.0782.234+1.844

1.4. Solvency of Pangaea Oncology S.A..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Pangaea Oncology S.A. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare¬†Pangaea Oncology S.A. to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.19¬†means that Pangaea Oncology S.A. assets are¬†financed with 18.7% credit (debt) and the remaining percentage (100% - 18.7%)¬†is financed by its owners/shareholders.¬†

Let's take a look of the Debt to Asset Ratio trends of Pangaea Oncology S.A.:

  • The MRQ is 0.187. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.204. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.187TTM0.204-0.017
TTM0.204YOY0.324-0.121
TTM0.2045Y0.244-0.040
5Y0.24410Y0.2440.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1870.434-0.247
TTM0.2040.396-0.192
YOY0.3240.367-0.043
5Y0.2440.424-0.180
10Y0.2440.441-0.197
1.4.2. Debt to Equity Ratio

Measures if Pangaea Oncology S.A. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but¬†always compare¬†Pangaea Oncology S.A. to the¬†Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 23.0% means that company has €0.23 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Pangaea Oncology S.A.:

  • The MRQ is 0.230. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.257. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.230TTM0.257-0.027
TTM0.257YOY0.480-0.224
TTM0.2575Y0.331-0.075
5Y0.33110Y0.3310.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2300.618-0.388
TTM0.2570.570-0.313
YOY0.4800.478+0.002
5Y0.3310.635-0.304
10Y0.3310.717-0.386

2. Market Valuation of Pangaea Oncology S.A.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures¬†how much money you pay¬†for each share for¬†every €1 in earnings Pangaea Oncology S.A. generates.

  • Above 15 is considered overpriced but¬†always compare¬†Pangaea Oncology S.A. to the¬†Diagnostics & Research industry mean.
  • A PE ratio of -6.99 means the investor is paying €-6.99¬†for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Pangaea Oncology S.A.:

  • The EOD is -7.548. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.994. Based on the earnings, the company is expensive. -2
  • The TTM is -10.060. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.548MRQ-6.994-0.554
MRQ-6.994TTM-10.060+3.067
TTM-10.060YOY-15.463+5.403
TTM-10.0605Y-11.861+1.801
5Y-11.86110Y-11.8610.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-7.548-0.571-6.977
MRQ-6.994-0.843-6.151
TTM-10.060-0.578-9.482
YOY-15.463-0.194-15.269
5Y-11.8611.627-13.488
10Y-11.8613.947-15.808
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Pangaea Oncology S.A.:

  • The EOD is -3.645. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.378. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -7.125. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.645MRQ-3.378-0.268
MRQ-3.378TTM-7.125+3.748
TTM-7.125YOY-4.502-2.623
TTM-7.1255Y-6.251-0.874
5Y-6.25110Y-6.2510.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-3.645-1.010-2.635
MRQ-3.378-1.354-2.024
TTM-7.125-1.169-5.956
YOY-4.502-2.135-2.367
5Y-6.251-1.356-4.895
10Y-6.251-2.108-4.143
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Pangaea Oncology S.A. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy¬†(always compare to Diagnostics & Research industry mean).
  • A PB ratio of 2.16 means the investor is paying €2.16¬†for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Pangaea Oncology S.A.:

  • The EOD is 2.335. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.164. Based on the equity, the company is underpriced. +1
  • The TTM is 2.035. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.335MRQ2.164+0.172
MRQ2.164TTM2.035+0.129
TTM2.035YOY3.235-1.200
TTM2.0355Y2.435-0.400
5Y2.43510Y2.4350.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD2.3351.799+0.536
MRQ2.1642.108+0.056
TTM2.0352.155-0.120
YOY3.2352.517+0.718
5Y2.4353.450-1.015
10Y2.4354.040-1.605
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Pangaea Oncology S.A. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0810.140-158%0.478-117%0.253-132%0.253-132%
Book Value Per Share--0.7580.799-5%0.478+58%0.692+10%0.692+10%
Current Ratio--4.8864.944-1%2.362+107%4.083+20%4.083+20%
Debt To Asset Ratio--0.1870.204-8%0.324-42%0.244-23%0.244-23%
Debt To Equity Ratio--0.2300.257-11%0.480-52%0.331-31%0.331-31%
Dividend Per Share----0%-0%-0%-0%
Eps---0.059-0.045-24%-0.025-57%-0.038-35%-0.038-35%
Free Cash Flow Per Share---0.121-0.079-35%-0.086-29%-0.081-33%-0.081-33%
Free Cash Flow To Equity Per Share--0.1910.266-28%0.086+121%0.206-8%0.206-8%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap52118889.000+4%49927864.80049309772.400+1%45558387.040+10%48059310.613+4%48059310.613+4%
Net Profit Margin---0.850-0.630-26%-0.345-59%-0.535-37%-0.535-37%
Operating Margin----0%-0%-0%-0%
Operating Ratio--0.7050.510+38%0.266+165%0.429+65%0.429+65%
Pb Ratio2.335+7%2.1642.035+6%3.235-33%2.435-11%2.435-11%
Pe Ratio-7.548-8%-6.994-10.060+44%-15.463+121%-11.861+70%-11.861+70%
Price Per Share1.770+7%1.6401.620+1%1.547+6%1.596+3%1.596+3%
Price To Free Cash Flow Ratio-3.645-8%-3.378-7.125+111%-4.502+33%-6.251+85%-6.251+85%
Price To Total Gains Ratio-21.765-8%-20.166-7.867-61%3.235-723%-4.166-79%-4.166-79%
Quick Ratio--5.0084.948+1%2.336+114%4.078+23%4.078+23%
Return On Assets---0.063-0.046-28%-0.035-44%-0.042-33%-0.042-33%
Return On Equity---0.077-0.057-27%-0.052-32%-0.055-28%-0.055-28%
Total Gains Per Share---0.0810.140-158%0.478-117%0.253-132%0.253-132%
Usd Book Value--24845838.75726173472.306-5%15165330.267+64%22504091.626+10%22504091.626+10%
Usd Book Value Change Per Share---0.0880.151-158%0.515-117%0.272-132%0.272-132%
Usd Book Value Per Share--0.8160.860-5%0.515+58%0.745+10%0.745+10%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.063-0.048-24%-0.027-57%-0.041-35%-0.041-35%
Usd Free Cash Flow---3978944.850-2592176.784-35%-2723846.427-32%-2636066.665-34%-2636066.665-34%
Usd Free Cash Flow Per Share---0.131-0.085-35%-0.093-29%-0.088-33%-0.088-33%
Usd Free Cash Flow To Equity Per Share--0.2050.287-28%0.093+121%0.222-8%0.222-8%
Usd Market Cap56116407.786+4%53757332.03053091831.943+1%49052715.326+10%51745459.737+4%51745459.737+4%
Usd Price Per Share1.906+7%1.7661.744+1%1.666+6%1.718+3%1.718+3%
Usd Profit---1921683.393-1460075.186-24%-793075.686-59%-1237742.019-36%-1237742.019-36%
Usd Revenue--2259594.9212351388.980-4%2299368.219-2%2334048.726-3%2334048.726-3%
Usd Total Gains Per Share---0.0880.151-158%0.515-117%0.272-132%0.272-132%
 EOD+5 -3MRQTTM+6 -26YOY+13 -195Y+11 -2110Y+11 -21

3.2. Fundamental Score

Let's check the fundamental score of Pangaea Oncology S.A. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.548
Price to Book Ratio (EOD)Between0-12.335
Net Profit Margin (MRQ)Greater than0-0.850
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than15.008
Current Ratio (MRQ)Greater than14.886
Debt to Asset Ratio (MRQ)Less than10.187
Debt to Equity Ratio (MRQ)Less than10.230
Return on Equity (MRQ)Greater than0.15-0.077
Return on Assets (MRQ)Greater than0.05-0.063
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Pangaea Oncology S.A. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.439
Ma 20Greater thanMa 501.842
Ma 50Greater thanMa 1001.818
Ma 100Greater thanMa 2001.824
OpenGreater thanClose1.770
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets25,456
Total Liabilities5,608
Total Stockholder Equity19,703
 As reported
Total Liabilities 5,608
Total Stockholder Equity+ 19,703
Total Assets = 25,456

Assets

Total Assets25,456
Total Current Assets10,126
Long-term Assets15,330
Total Current Assets
Cash And Cash Equivalents 3,528
Short-term Investments 1,409
Inventory 452
Total Current Assets  (as reported)10,126
Total Current Assets  (calculated)5,389
+/- 4,737
Long-term Assets
Property Plant Equipment 459
Goodwill 518
Intangible Assets 9,926
Long-term Assets Other 1,751
Long-term Assets  (as reported)15,330
Long-term Assets  (calculated)12,654
+/- 2,676

Liabilities & Shareholders' Equity

Total Current Liabilities3,669
Long-term Liabilities1,939
Total Stockholder Equity19,703
Total Current Liabilities
Short-term Debt 1,759
Accounts payable 1,132
Other Current Liabilities 18
Total Current Liabilities  (as reported)3,669
Total Current Liabilities  (calculated)2,909
+/- 761
Long-term Liabilities
Long-term Liabilities  (as reported)1,939
Long-term Liabilities  (calculated)0
+/- 1,939
Total Stockholder Equity
Common Stock610
Retained Earnings -8,568
Other Stockholders Equity 27,662
Total Stockholder Equity (as reported)19,703
Total Stockholder Equity (calculated)19,703
+/-0
Other
Cash and Short Term Investments 4,937
Current Deferred Revenue761
Liabilities and Stockholders Equity 25,456
Net Debt -135
Short Long Term Debt Total 3,393



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-06-302022-12-312022-06-302021-12-312021-06-30
> Total Assets 
21,762
20,850
32,787
28,377
25,456
25,45628,37732,78720,85021,762
   > Total Current Assets 
9,808
7,521
18,425
13,308
10,126
10,12613,30818,4257,5219,808
       Cash And Cash Equivalents 
4,188
2,020
12,363
7,103
3,528
3,5287,10312,3632,0204,188
       Short-term Investments 
661
911
907
1,411
1,409
1,4091,411907911661
       Net Receivables 
0
3,597
3,828
3,715
0
03,7153,8283,5970
       Inventory 
756
401
648
235
452
452235648401756
   > Long-term Assets 
11,954
13,329
14,362
15,069
15,330
15,33015,06914,36213,32911,954
       Property Plant Equipment 
506
429
380
353
459
459353380429506
       Goodwill 
0
49
628
599
518
518599628490
       Intangible Assets 
7,503
8,227
8,992
9,588
9,926
9,9269,5888,9928,2277,503
       Long-term Assets Other 
1,642
2,965
1,306
1,655
1,751
1,7511,6551,3062,9651,642
> Total Liabilities 
7,899
6,765
7,245
5,301
5,608
5,6085,3017,2456,7657,899
   > Total Current Liabilities 
4,184
3,185
3,683
2,724
3,669
3,6692,7243,6833,1854,184
       Short-term Debt 
2,902
2,090
1,867
1,208
1,759
1,7591,2081,8672,0902,902
       Accounts payable 
987
736
1,191
863
1,132
1,1328631,191736987
       Other Current Liabilities 
296
359
0
653
18
186530359296
   > Long-term Liabilities 
3,715
3,580
3,562
2,578
1,939
1,9392,5783,5623,5803,715
       Long term Debt Total 
0
1,927
1,562
1,227
0
01,2271,5621,9270
> Total Stockholder Equity
13,862
14,085
25,542
23,076
19,703
19,70323,07625,54214,08513,862
   Common Stock
375
451
610
610
610
610610610451375
   Retained Earnings -8,568-7,854-5,403-4,494-3,604
   Capital Surplus 
0
16,311
28,506
28,506
0
028,50628,50616,3110
   Treasury Stock00000
   Other Stockholders Equity 
17,091
18,128
30,335
30,321
27,662
27,66230,32130,33518,12817,091



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue4,368
Cost of Revenue-256
Gross Profit4,1124,112
 
Operating Income (+$)
Gross Profit4,112
Operating Expense-6,310
Operating Income2,559-2,198
 
Operating Expense (+$)
Research Development0
Selling General Administrative1,207
Selling And Marketing Expenses71
Operating Expense6,3101,278
 
Net Interest Income (+$)
Interest Income228
Interest Expense-189
Other Finance Cost-39
Net Interest Income0
 
Pretax Income (+$)
Operating Income2,559
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-2,8397,956
EBIT - interestExpense = -2,606
-2,827
-2,523
Interest Expense189
Earnings Before Interest and Taxes (EBIT)-2,416-2,649
Earnings Before Interest and Taxes (EBITDA)-1,176
 
After tax Income (+$)
Income Before Tax-2,839
Tax Provision--115
Net Income From Continuing Ops0-2,724
Net Income-2,712
Net Income Applicable To Common Shares-2,712
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses6,565
Total Other Income/Expenses Net-5,3970
 

Technical Analysis of Pangaea Oncology S.A.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pangaea Oncology S.A.. The general trend of Pangaea Oncology S.A. is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pangaea Oncology S.A.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Pangaea Oncology S.A..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.8 < 1.8 < 1.8.

The bearish price targets are: 1.69 > 1.69 > 1.69.

Tweet this
Pangaea Oncology S.A. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging¬†trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Pangaea Oncology S.A.. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Pangaea Oncology S.A. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a¬†lagging momentum¬†indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Pangaea Oncology S.A.. The current macd is 0.0070879.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pangaea Oncology S.A. price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Pangaea Oncology S.A.. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Pangaea Oncology S.A. price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Pangaea Oncology S.A. Daily Moving Average Convergence/Divergence (MACD) ChartPangaea Oncology S.A. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Pangaea Oncology S.A.. The current adx is 26.85.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Pangaea Oncology S.A. shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Pangaea Oncology S.A. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows¬†the current trend.
  • Shows¬†potential entry signals.
  • Shows¬†¬†potential exit signals.
  • Can be used to place¬†trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Pangaea Oncology S.A.. The current sar is 1.86.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Pangaea Oncology S.A. Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum¬†indicator, meaning the signals are instant.
  • Ranges¬†between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Pangaea Oncology S.A.. The current rsi is 33.44. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Pangaea Oncology S.A. Daily Relative Strength Index (RSI) ChartPangaea Oncology S.A. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading¬†momentum¬†indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges¬†between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Pangaea Oncology S.A.. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pangaea Oncology S.A. price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Pangaea Oncology S.A. Daily Stochastic Oscillator ChartPangaea Oncology S.A. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,¬†the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Pangaea Oncology S.A.. The current cci is -210.93148576.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Pangaea Oncology S.A. Daily Commodity Channel Index (CCI) ChartPangaea Oncology S.A. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Pangaea Oncology S.A.. The current cmo is -51.082929.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Pangaea Oncology S.A. Daily Chande Momentum Oscillator (CMO) ChartPangaea Oncology S.A. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and¬†-100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Pangaea Oncology S.A.. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Pangaea Oncology S.A. Daily Williams %R ChartPangaea Oncology S.A. Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold¬†

Score

Let's take a look at the Bollinger Bands of Pangaea Oncology S.A..

Pangaea Oncology S.A. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Pangaea Oncology S.A.. The current atr is 0.0254125.

Pangaea Oncology S.A. Daily Average True Range (ATR) ChartPangaea Oncology S.A. Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Pangaea Oncology S.A.. The current obv is 697,019.

Pangaea Oncology S.A. Daily On-Balance Volume (OBV) ChartPangaea Oncology S.A. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Pangaea Oncology S.A.. The current mfi is 39.28.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Pangaea Oncology S.A. Daily Money Flow Index (MFI) ChartPangaea Oncology S.A. Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Pangaea Oncology S.A..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-01-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-31CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-20MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-26MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-02MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-29RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-05-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-05-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-05-23MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-05-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Pangaea Oncology S.A. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Pangaea Oncology S.A. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.439
Ma 20Greater thanMa 501.842
Ma 50Greater thanMa 1001.818
Ma 100Greater thanMa 2001.824
OpenGreater thanClose1.770
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Pangaea Oncology S.A. with someone you think should read this too:
  • Are you bullish or bearish on Pangaea Oncology S.A.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pangaea Oncology S.A.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Pangaea Oncology S.A.

I send you an email if I find something interesting about Pangaea Oncology S.A..


Comments

How you think about this?

Leave a comment

Stay informed about Pangaea Oncology S.A..

Receive notifications about Pangaea Oncology S.A. in your mailbox!